Prevoznik Michael E's Form 4 filing
Quest Diagnostics Inc (DGX) · filed Mar 5, 2025
- Accession no.
- 0001022079-25-000087
- Filed
- Mar 5, 2025
- Trade date
- Mar 3-4, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 0 derivative transactions. Open-market sales total $104.1K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Prevoznik Michael ECIK 0001222679 | Officer (SVP & General Counsel) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 3, 2025 | Common Stock | FTax withholdingDisposed | −322 | $173.74 | −$55,944.28 | 38,709 | Direct | |
| Mar 4, 2025 | Common Stock | SSaleDisposed | −592 | $175.79 | −$104,067.68 | 38,117 | Direct | |
| Mar 4, 2025 | Common Stock | AGrant or awardAcquired | +8,549 | $173.74 | +$1,485,303.26 | 46,666 | Direct | |
| Mar 4, 2025 | Common Stock | FTax withholdingDisposed | −3,906 | $173.74 | −$678,628.44 | 42,760 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.